Crohn's disease (reference and links)

Authors : Adam S. Cheifetz MD Center for Inflammatory Bowel Disease, Alan C. Moss MD Beth Israel Deaconess Medical Center, Mark A. Peppercorn MD Harvard Medical School Boston, MA.

2008-10-20

Crypt branching

Reference

1. Lichtenstein GR, Abreu MT, Cohen R, Tremaine W.  American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology 2006;130(3):940-987. 
2. Langmead L, Rampton DS. Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther. 2006 Feb 1;23(3):341-9.  
3. Caprilli R, Gassull MA, Escher JC, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations. Gut 2006;55, Suppl 1:i36-58. 
4. Travis SP, Stange EF, Lemann M, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: current management. Gut 2006;55, Suppl 1:i16-35. 
5. Stange EF, Travis SP, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. Gut 2006;55, Suppl 1:i1-15 
6. Lichtenstein GR, Sands BE, Pazianas M. Prevention and treatment of osteoporosis in inflammatory bowel disease. Inflamm Bowel Dis 2006;12(8):797-813.
7. Vermeire S, Rutgeerts P. Current status of genetics research in inflammatory bowel disease. Genes Immun. 2005 Dec;6(8):637-4.
8. Carter, MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53 Suppl 5:v1-16. 
9. Sands BE, Cuffari C, Katz J, et al. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis;10(5):677-92.
10. Egan LJ, Sandborn WJ. Advances in the treatment of Crohn's disease. Gastroenterology. 2004;126(6):1574-81. 
11. Hommes DW, van Deventer SJ. Endoscopy in inflammatory bowel diseases. Gastroenterology. 2004;126(6):1561-73. 
12. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology. 2004;126(6):1620-33. 
13. Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB; American Gastroenterological Association Clinical Practice Committee. AGA technical review on perianal Crohn's disease. Gastroenterology. 2003;125(5):1508-30. 
14. Pearson DC, May GR, Fick GH et al.  Azathioprine and 6-mercaptopurine in Crohn’s disease. A meta-analysis. Ann Intern Med. 1995;123:132-142.

LinksThere are a lot of websites with information on ulcerative colitis, but many are simply selling or promoting a product, or have unverified information. The sites below provide reliable information for patients.

Crohn’s & Colitis Foundation of America

http://www.ccfa.org/

European Federation of Crohn's & Ulcerative Colitis Associations

http://www.efcca.org/

Clinical trials conducted in the United States and around the world

http://clinicaltrials.gov/

National Digestive Diseases Information Clearinghouse (NDDIC) for patient information on Crohn’s disease

http://digestive.niddk.nih.gov/ddiseases/pubs/crohns/index.htm

National Library of Medicine’s patient information page on Crohn’s disease

http://www.nlm.nih.gov/medlineplus/crohnsdisease.html

National Health Service (United Kingdom) – patient information on Crohn’s disease

http://www.nhsdirect.nhs.uk/articles/article.aspx?articleId=115

Health On the Net (HON) – a United Nations resource for searching health-related websites that comply with a code of practice in distributing health information to patients

http://www.hon.ch/individuals.html